Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats

Toxicology and Applied Pharmacology

Volumn 247, Issue 2, 2010, Pages 83-90

  Singh, Bhupendra ^a   Mense, Sarah M ^b   Bhat, Nimee K ^a   Putty, Sandeep ^a   Guthiel, William A ^a   Remotti, Fabrizio ^b   Bhat, Hari K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

ACI rat; Breast cancer; Estrogen; Phytoestrogen; Quercetin

Indexed keywords

8 ISOPROSTANE; CATECHOL METHYLTRANSFERASE; ESTROGEN; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST TUMOR; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN METABOLISM; EXPOSURE; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; LATENT PERIOD; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALIA; RATTUS;

EID: 77955272128     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.06.011     Document Type: Article

References (67)

1. Allred C.D., Allred K.F., Ju Y.H., Clausen L.M., Doerge D.R., Schantz S.L., Korol D.L., Wallig M.A., Helferich W.G. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis 2004, 25:211-218.
2. Arnerlov C., Emdin S.O., Cajander S., Bengtsson N.O., Tavelin B., Roos G. Intratumoral variations in DNA ploidy and S-phase fraction in human breast cancer. Anal. Cell. Pathol. 2001, 23:21-28.
3. Bai H.W., Shim J.Y., Yu J., Zhu B.T. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem. Res. Toxicol. 2007, 20:1409-1425.
4. Balabhadrapathruni S., Thomas T.J., Yurkow E.J., Amenta P.S., Thomas T. Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cells. Oncol. Rep. 2000, 7:3-12.
5. Banerjee S., Bueso-Ramos C., Aggarwal B.B. Suppression of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002, 62:4945-4954.
6. Bhat H.K., Epelboym I. Suppression of calbindin D28K in estrogen-induced hamster renal tumors. J. Steroid Biochem. Mol. Biol. 2004, 92:391-398.
7. Bhat K.P., Lantvit D., Christov K., Mehta R.G., Moon R.C., Pezzuto J.M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001, 61:7456-7463.
8. Bhat H.K., Calaf G., Hei T.K., Loya T., Vadgama J.V. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl Acad. Sci. U. S. A. 2003, 100:3913-3918.
9. Bock K.W., Matern S. Immunochemical studies on rat-liver microsomal NAD glycohydrolase. Eur. J. Biochem. 1973, 38:20-24.
10. Brooks J.D., Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 2005, 94:461-467.
11. Brueggemeier R.W., Bhat A.S., Lovely C.J., Coughenour H.D., Joomprabutra S., Weitzel D.H., Vandre D.D., Yusuf F., Burak W.E. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. J. Steroid Biochem. Mol. Biol. 2001, 78:145-156.
12. Connolly K.M., Bogdanffy M.S. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J. Histochem. Cytochem. 1993, 41:1-6.
13. Constantinou A.I., Lantvit D., Hawthorne M., Xu X., van Breemen R.B., Pezzuto J.M. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr. Cancer 2001, 41:75-81.
14. Fritz W.A., Coward L., Wang J., Lamartiniere C.A. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998, 19:2151-2158.
15. Galati G., O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37:287-303.
16. Graf B.A., Ameho C., Dolnikowski G.G., Milbury P.E., Chen C.Y., Blumberg J.B. Rat gastrointestinal tissues metabolize quercetin. J. Nutr. 2006, 136:39-44.
17. Han X., Liehr J.G. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 1994, 15:997-1000.
18. Harris D.M., Besselink E., Henning S.M., Go V.L., Heber D. Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med. (Maywood) 2005, 230:558-568.
19. Harvell D.M., Strecker T.E., Tochacek M., Xie B., Pennington K.L., McComb R.D., Roy S.K., Shull J.D. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc. Natl Acad. Sci. U. S. A. 2000, 97:2779-2784.
20. Hilakivi-Clarke L., Onojafe I., Raygada M., Cho E., Skaar T., Russo I., Clarke R. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 1999, 80:1682-1688.
21. Hodek P., Trefil P., Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 2002, 139:1-21.
22. Hou Y.C., Chao P.D., Ho H.J., Wen C.C., Hsiu S.L. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J. Pharm. Pharmacol. 2003, 55:199-203.
23. Jin Z., MacDonald R.S. Soy isoflavones increase latency of spontaneous mammary tumors in mice. J. Nutr. 2002, 132:3186-3190.
24. Kijkuokool P., Parhar I.S., Malaivijitnond S. Genistein enhances N-nitrosomethylurea-induced rat mammary tumorigenesis. Cancer Lett. 2006, 242:53-59.
25. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
26. Lamartiniere C.A., Zhang J.X., Cotroneo M.S. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. Am. J. Clin. Nutr. 1998, 68:1400S-1405S.
27. LaVallee T.M., Zhan X.H., Herbstritt C.J., Kough E.C., Green S.J., Pribluda V.S. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 2002, 62:3691-3697.
28. Le Corre L., Chalabi N., Delort L., Bignon Y.J., Bernard-Gallon D.J. Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 2005, 49:462-471.
29. Lehmann L., Jiang L., Wagner J. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells. Carcinogenesis 2008, 29:363-370.
30. Li J.J., Papa D., Davis M.F., Weroha S.J., Aldaz C.M., El-Bayoumy K., Ballenger J., Tawfik O., Li S.A. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: comparison to invasive human ductal breast cancer. Mol. Carcinog. 2002, 33:56-65.
31. Li S.A., Weroha S.J., Tawfik O., Li J.J. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation. J. Endocrinol. 2002, 175:297-305.
32. Li J.J., Weroha S.J., Lingle W.L., Papa D., Salisbury J.L., Li S.A. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc. Natl Acad. Sci. U. S. A. 2004, 101:18123-18128.
33. Limer J.L., Parkes A.T., Speirs V. Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro. Int. J. Cancer 2006, 119:515-521.
34. Makris A., Allred D.C., Powles T.J., Dowsett M., Fernando I.N., Trott P.A., Ashley S.E., Ormerod M.G., Titley J.C., Osborne C.K. Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Res. Treat. 1997, 44:65-74.
35. Mense S.M., Chhabra J., Bhat H.K. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin. J. Steroid Biochem. Mol. Biol. 2008, 110:157-162.
36. Mense S.M., Remotti F., Bhan A., Singh B., El-Tamer M., Hei T.K., Bhat H.K. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol. Appl. Pharmacol. 2008, 232:78-85.
37. Mense S.M., Singh B., Remotti F., Liu X., Bhat H.K. Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats. Carcinogenesis 2009, 30:1202-1208.
38. Messina M., McCaskill-Stevens W., Lampe J.W. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J. Natl. Cancer Inst. 2006, 98:1275-1284.
39. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl Acad. Sci. U. S. A. 1990, 87:9383-9387.
40. Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., Lamartiniere C.A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996, 17:1451-1457.
41. Nagai M., Conney A.H., Zhu B.T. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. 2004, 32:497-504.
42. Nichenametla S.N., Taruscio T.G., Barney D.L., Exon J.H. A review of the effects and mechanisms of polyphenolics in cancer. Crit. Rev. Food Sci. Nutr. 2006, 46:161-183.
43. Peeters P.H., Keinan-Boker L., van der Schouw Y.T., Grobbee D.E. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res. Treat. 2003, 77:171-183.
44. Pike M.C., Kolonel L.N., Henderson B.E., Wilkens L.R., Hankin J.H., Feigelson H.S., Wan P.C., Stram D.O., Nomura A.M. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol. Biomark. Prev. 2002, 11:795-800.
45. Pratico D., Lawson J.A., FitzGerald G.A. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha. J. Biol. Chem. 1995, 270:9800-9808.
46. Probst-Hensch N.M., Pike M.C., McKean-Cowdin R., Stanczyk F.Z., Kolonel L.N., Henderson B.E. Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br. J. Cancer 2000, 82:1867-1870.
47. Rodgers E.H., Grant M.H. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chem. Biol. Interact. 1998, 116:213-228.
48. Sato M., Pei R.J., Yuri T., Danbara N., Nakane Y., Tsubura A. Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Lett. 2003, 202:137-145.
49. Schumacher G., Neuhaus P. 2-Methoxyestradiol-a new compound for cancer treatment. Dtsch Med. Wochenschr. 2006, 131:825-830.
50. Shull J.D., Spady T.J., Snyder M.C., Johansson S.L., Pennington K.L. Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis 1997, 18:1595-1601.
51. Singh B., Mense S.M., Remotti F., Liu X., Bhat H.K. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats. J. Biochem. Mol. Toxicol. 2009, 23:202-211.
52. Sirtori C.R., Arnoldi A., Johnson S.K. Phytoestrogens: end of a tale?. Ann. Med. 2005, 37:423-438.
53. Stopper H., Schmitt E., Kobras K. Genotoxicity of phytoestrogens. Mutat. Res. 2005, 574:139-155.
54. Ursin G., Bernstein L., Pike M.C. Breast cancer. Cancer Surv. 1994, 19-20:241-264.
55. Usui T. Pharmaceutical prospects of phytoestrogens. Endocr. J. 2006, 53:7-20.
56. van der Woude H., Ter Veld M.G., Jacobs N., van der Saag P.T., Murk A.J., Rietjens I.M. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol. Nutr. Food Res. 2005, 49:763-771.
57. van Duursen M.B., Sanderson J.T., de Jong P.C., Kraaij M., van den Berg M. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. Toxicol. Sci. 2004, 81:316-324.
58. Verma A.K., Johnson J.A., Gould M.N., Tanner M.A. Inhibition of 7, 12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res. 1988, 48:5754-5758.
59. Wang M.Y., Liehr J.G. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 1995, 16:1941-1945.
60. Wang Y., Cao J., Weng J.H., Zeng S. Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2005, 39:328-333.
61. Weroha S.J., Li S.A., Tawfik O., Li J.J. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis 2006, 27:491-498.
62. Whitsett T., Carpenter M., Lamartiniere C.A. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J. Carcinog. 2006, 5:15.
63. Yang C.S., Landau J.M., Huang M.T., Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr. 2001, 21:381-406.
64. Zhu B.T. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr. Drug Metab. 2002, 3:321-349.
65. Zhu B.T., Conney A.H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?. Cancer Res. 1998, 58:2269-2277.
66. Zhu B.T., Liehr J.G. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 1994, 125:149-158.
67. Zhu B.T., Liehr J.G. Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J. Biol. Chem. 1996, 271:1357-1363.